A new method of blocking the genesis of blood vessels that feed tumors may start with the nuclear receptor COUP-TFII, said researchers who have studied the factor for more than 20 years.
A new method of blocking the genesis of blood vessels that feed tumors may start with the nuclear receptor COUP-TFII, said researchers who have studied the factor for more than 20 years.